Probiotic potential of novel strains of Lactobacillus plantarum Lp -1: In vitro studies.
Five Lactobacillus strains isolated from vegetable and dairy products showed 99% similarity with Lactobacillus plantarum 1(Lp-1) using API -CHL 50 kit. Most of them proved to be sensitive to bacterial cell-wall inhibitors i.e. penicillin, ampicillin, amoxicillin and methicillin as studied by disc-diffusion method. These strains manifested profound tolerance to acidic-stress where Lp86 and Lp36 exhibited a good survival pattern at pH-2 for 4 hr retaining a survival count of 85% and 50%, respectively. A high survival of 85.7% was witnessed in Lp86 in presence of protease while Lp36 maintained 94.55% and 92.65% of population under the influence of enzyme pancreatin and pepsin. All the strains displayed marked tolerance against trypsin as the count did not drop below 77%. Absorbance and growth in terms of cfu/ml for bile-tolerance was examined for concentrations reflecting those in the GIT of humans, all the Lp-1 strains when grown with 1% bile showed a drop in the viable count by 1 log cycle i.e. from 1010 to 109cfu/ml. Fulfilling the above mentioned criteria these probiotic candidates displayed their capacity to reach the colon as viable metabolically active cells after successfully surviving under conditions similar to the gastrointestinal tract of humans. Upon examining the viability and stability of these probiotic candidates in most common foods serving as vehicle for probiotic delivery to the intestine, it was noticed that all the isolates tested sustained a probiotic approved number of 107 cfu/ml for effective function as recommended by WHO, after a maximum storage for one month. Hence, it could be justified that the selected probiotic candidates possess prominent probiotic potential. Therefore, L. plantarum 1 strains could prove to be an efficient probiotic after further in vivo studies to explore its safety in human subjects.